Emma's Fargo Experience
Finding Hope Through Research
My name is Emma. I’m 45, a mum to three girls, and in January 2025 I was diagnosed with large duct primary sclerosing cholangitis (PSC).
Getting that diagnosis had been a long and unsettling journey. My liver function tests had remained raised for almost two years. In June 2024, I spent ten days in hospital with an infection affecting my liver, bile ducts and gallbladder, followed by gallbladder removal that August. Yet I was still no closer to understanding what was happening.
I had been diagnosed with ulcerative colitis in 2021, and PSC had been mentioned as a possibility during tests regarding my raised LFTs. An MRCP at my local hospital in Scotland showed irregularities in my bile ducts, but no diagnosis followed. I found the uncertainty increasingly difficult. With young children, including my youngest who is disabled, I needed answers.
In November 2024, I travelled to London to see a PSC specialist consultant Dr Joshi privately. Following further investigations, he confirmed my diagnosis in January 2025.
Although I had been searching for an explanation, receiving one was devastating. I turned to Google and frightened myself with what I read. I came away believing I might have only ten years if I was lucky - not because my consultant had given me that prognosis, but because fear had shaped how I understood the information. All I could think about was my girls. I wanted to watch them grow up and be there when they needed me.
Choosing to Take Part
Dr Joshi suggested that I might be a suitable candidate for a clinical trial. Once home, I began looking through the PSC Support website and came across FARGO. I emailed Professor Trivedi to ask whether I could be considered. Within a few days, someone called to talk me through the details.
Taking part felt like something I could do when so much seemed beyond my control. I come from a family of strong women, and I wanted to meet this diagnosis with that determination. I wanted to help research move forward, both for my own family and for people facing the uncertainty of PSC.
The screening process was clear. The team had access to my scans and diagnostic information, and I completed forms and answered questions about my medical history. My first appointment at Queen Elizabeth Hospital in Birmingham was in February 2025, just six weeks after my diagnosis.
Life Around the Trial
I took part in FARGO for 13 months, beginning with weekly visits before moving to more widely spaced follow-up appointments.
During the trial, I had two colonoscopies, biopsies and two FibroScans, alongside blood tests at various stages. I completed regular questionnaires about my symptoms and wellbeing and provided stool samples during the early weeks of faecal microbiota transplantation (FMT). After treatment, I would lie down for around 20 minutes, often spent chatting with my lovely nurse and putting the world to rights.
There was humour among the practicalities. Preparing for my first colonoscopy in a hotel, I discovered I had forgotten a measuring jug. The hotel kindly lent me a shot measure, which wasn’t quite what I had imagined using for bowel preparation! The disposable modesty shorts also made the cut in the weekly updates I shared on facebook with my family and friends.
The traveling from Scotland to Birmingham each week meant early flights and nights away, but having family nearby made a real difference. I spent my childhood in Birmingham and my siblings still reside there. My amazing sister-in-law and brothers helped with lifts and a place to stay, and spending time together gave me something to look forward to between appointments.
My middle daughter sometimes joined me as my travel companion. We found opportunities to make memories along the way, including taking the sleeper train and visiting the Tutankhamun exhibition in London. Those moments brought some ordinary family happiness into a period otherwise dominated by illness and uncertainty.
Feeling supported, finding confidence
What stays with me most is the care I received from the FARGO team.
After the difficult journey to diagnosis, my confidence had suffered. Being listened to, having my questions answered and feeling that my concerns mattered helped me begin to rebuild it. The doctors and nurses were dedicated and helpful, and I felt cared for throughout.
Over the course of the trial, I also noticed improvements in my general wellbeing and stomach symptoms. My mental health improved after the distress of diagnosis. I cannot say whether the trial treatment caused those changes, but they were a meaningful part of my experience.
Taking part in FARGO was empowering. It gave me purpose and a way to contribute when I felt frightened and powerless. I couldn’t remove the uncertainty of PSC, but I could play a part in the search for answers.
My girls were at the heart of that decision. I wanted to be here for them, and I wanted to do whatever I could to help create a future with better treatments for people living with PSC.
For me, FARGO offered the opportunity to turn some of that fear into hope, and to feel reassured while doing so.
Thank you to Emma for telling us about her experience of taking part in the Fargo Clinical Trial. If you'd like to share your experience, please get in touch!
More on Living with PSC
-
Antonio’s Story: from PSC & UC diagnosis to the London Marathon Starting Line
-
Parastoo’s Story: Waiting, Wondering and Learning
-
Lindsay’s Story: Life, Motherhood, and PSC
-
Calum’s Journey: from Football to PSC
-
Leanne – Living with PSC and Why Awareness Matters
-
Gemma – Life as a Single Parent with Multiple Autoimmune Conditions
-
Nick – Childhood Diagnosis to Advocacy
-
Claire Participating in Clinical Trials
-
Alison Changing Diet
-
James’ Liverversary
-
Tom
-
David PSC Story
-
Katherine – Bacterial Cholangitis Parody Song
-
Katie – Liver Biopsy Experience
-
Maria
-
Louise’s Lockdown Raffle
-
Carol
-
James
-
Kevin – Cholangitis Attacks
-
Sheila

Getting that diagnosis had been a long and unsettling journey. My liver function tests had remained raised for almost two years. In June 2024, I spent ten days in hospital with an infection affecting my liver, bile ducts and gallbladder, followed by gallbladder removal that August. Yet I was still no closer to understanding what was happening.
Dr Joshi suggested that I might be a suitable candidate for a clinical trial. Once home, I began looking through the PSC Support website and came across FARGO. I emailed Professor Trivedi to ask whether I could be considered. Within a few days, someone called to talk me through the details.

